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Antifungal azoleEPR spectroscopywas applied to investigate the effects of the treatment of Candida albicans cellswithﬂuconazole
(FLC) and two newly synthesized azoles (CPA18 and CPA109), in a concentration not altering yeast morphology,
on the lipid organization and dynamics of the plasmamembrane.Measurements were performed in the temper-
ature range between 0 °C and 40 °C using 5-doxyl- (5-DSA) and 16-doxyl- (16-DSA) stearic acids as spin probes.
5-DSA spectra were typical of lipids in a highly ordered environment, whereas 16-DSA spectra consisted of two
comparable components, one corresponding to a ﬂuid bulk lipid domain in themembrane and the other to highly
ordered and motionally restricted lipids interacting with integral membrane proteins. A line shape analysis
allowed the relative proportion and the orientational order and dynamic parameters of the spin probes in the
different environments to be determined. Smaller order parameters, corresponding to a looser lipid packing,
were found for the treated samples with respect to the control one in the region close to the membrane surface
probed by 5-DSA. On the other hand, data on 16-DSA indicated that azole treatments hamper the formation of
ordered lipid domains hosting integral proteins and/or lead to a decrease in integral protein content in the
membrane. The observed effects are mainly ascribable to the inhibition of ergosterol biosynthesis by the antifungal
agents, although a direct interaction of the CPA compounds with the membrane bilayer in the region close to the
lipid polar head groups cannot be excluded.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Serious infections caused by opportunistic fungal pathogens are
increasingly common, especially in immunocompromised patients.
In particular, the incidence of candidiasis has increased 5-fold in
the past 10 years because of the widespread use of broad spectrum
antibiotics and the more and more expanded use of immunosup-
pressive agents, radiotherapy and antitumoral drugs [1–3]. Azole
antifungals, the major drugs used to treat pathogenic infections by
Candida albicans [4–6], act mainly by inhibiting the activity of sterol
14α-demethylase (Erg11p/CYP51p), the key enzyme in sterol bio-
synthesis in yeasts and molds [7–9]. As a consequence, depletion of
ergosterol and accumulation of toxic 14α-methyl-sterols occur in the
plasma membrane, leading to the inhibition of fungal cell growth. Al-
though azole antifungal agents are still considered the drugs of choice-doxylstearic acid; CPA18, 1-(1-
ole; CPA109, 1-(1-(biphenyl-4-
FLC, ﬂuconazole; EPR, Electron
dered macroscopically disor-
e; PS, phosphatidylserine; PI,
hatidic acid; FS, free sterols
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ights reserved.to treat most of the Candida infections, the resistance of C. albicans to
most clinically used azoles, especially ﬂuconazole (FLC, Fig. 1), is report-
ed with increasing frequency [10,11].
In the search for novel antifungal agents endowed with broad spec-
trum activities and able to overcome drug resistance, we have recently
presented two new azole compounds, CPA18 and CPA109 (Fig. 1) [12],
acting in vitro against an FLC-sensitive and two FLC-resistant C. albicans
strains, one with a mutation in Erg11 sequences and the other overex-
pressing the ABC transporter genes CDR1 and CDR2, which encode ATP-
dependent efﬂux pumps [13]. Moreover, while FLC has only fungistatic
action against C. albicans, the killing activity of CPA18 was remarkable
and fast on azole-susceptible as well as on azole-resistant strains. Investi-
gations aimed at ascertaining themechanism of action of CPA azoles indi-
cated that the binding afﬁnities of CPA18 and CPA109 for C. albicans
Erg11p are comparable to that of FLC. However, CPA compounds showed
a superior ability in blocking germ tube formation and, differently from
FLC, inhibited the polarization of sterols at the actively growing hyphal
tips and increased the permeability of cells [13]. Speciﬁc alterations in
the membrane lipid composition were also caused by the treatment of
C. albicans cellswith CPA compounds and FLC. As expected, all treatments
resulted in a dramatic reduction in the ergosterol content, with a corre-
sponding increase in the lanosterol one. However, a decrease of the free
sterols to phospholipids (FS/PL) molar ratio was found only for the CPA
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Fig. 2.Molecular structure of 5-DSA and 16-DSA.
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the content of all negatively charged PLs increased, with the only
exception of phosphatidylglycerol (PG) in FLC-treated cells, while
that of both phosphatidylcholine (PC) and phosphatidylethanolamine
(PE) decreased, the PC/PE molar ratio being reduced, especially for the
CPA treatments [13].
Lipid composition and organization of plasma membrane play a
multifaceted role in C. albicans physiology and drug susceptibility, by
mediating environment sensing, nutrient uptake, drug diffusion and
extrusion, virulence factor secretion, cellular morphogenesis, and cell
wall biogenesis [14–17]. Indeed, the organization of plasma membrane
proteins and lipids into lateral domains with different composition and
degree of order was recently reported for yeasts [15,18–22]. The pres-
ence of ergosterol modulates the thickness, ﬂuidity and permeability of
the plasma membrane. Its preferential association with sphingolipids to
form raft-like domains [23–26] confers membrane heterogeneity and fa-
cilitates speciﬁc functions of raft-associated proteins. In yeast, lipid rafts
have been found to be implicated in protein sorting, signal transduction,
secretion, endocytosis, and cell polarity [18,27–31].
The deleterious impact of altered sterol composition, and especially
ergosterol depletion, in membrane packing was reported by some
authors for the plasma membrane of C. albicans and Saccharomyces
cerevisiae by ﬂuorescence and EPR techniques [32–39]. Moreover, Erg
mutants which possess higher levels of membrane ﬂuidity were found
to be hypersensitive to drugs [36] and membrane ﬂuidity was shown
to increase in gradually ﬂuconazole adapted strains [38].
All this considered, an investigation of the effects induced on the
membrane physical state by the treatment of C. albicans cells by differ-
ent azole antifungals is valuable for the deeper understanding of the
mechanism of action and the difference in antimicotic activity of these
agents as well as for the development of novel therapeutic approaches.
To this aim, in the present work we applied spin probing EPR spectros-
copy, a very sensitive technique for obtaining information on the lipid
organization and dynamics in natural and model membranes [40–46],
to membrane vesicles isolated from C. albicans cells grown for about
12 h in the exponential phase in a medium containing or not CPA18,
CPA109, or FLC. To obtain membrane vesicles, the concentration usedfor the azole compounds was able to induce only a moderate reduction
in fungal growth compared to the control, without any alteration of
yeast morphology. Two spin probes were used, 5- and 16-doxyl-
stearic acids (5-DSA and 16-DSA in Fig. 2), to investigate the bilayer
properties close to the polar head groups and to the membrane core,
respectively. Indeed, although there is a distribution in the position
of the nitroxide moiety due to the presence of vertical ﬂuctuations
of the spin probe alkyl chain, the mean value of the distribution,
which may be considered accurate within 1.5–3.4 Å, certainly shifts
toward the center of the bilayer passing from 5- to 16-DSA [45]. In
particular, 5-DSA gives information on the average order and dynamic
properties of lipids close to the membrane surface and has already
been used to investigate C. albicans plasma membranes [47–49]. On
the other hand, 16-DSA, as other lipids that are spin-labeled close to
the methyl end of the acyl chains, can be exploited to distinguish and
characterize lipid domains directly interacting with the integral
membrane proteins and ﬂuid bilayer regions of the membrane
[42–44,46]. A spectral line shape analysis was performed in order
to obtain quantitative information on the organization of the plasma
membrane in domains with different degree of lipid orientational
order and dynamics, and on the effects of the antifungal treatments
on these properties.2. Materials and methods
2.1. Materials
CPA18 and CPA109 were prepared according to the previously
reported procedures [12].
FLC, 5-DSA and 16-DSA spin probes were purchased from Sigma-
Aldrich.2.2. Isolation of plasma membranes
An overnight culture of Candida SC5314 was diluted to 1.5 ×
104 cells/mL in yeast nitrogen base (YNB) containing 0.05 mg/L of
CPA109, CPA18, FLC or only vehicle (as control) and incubated
with shaking (160 rpm) at 28 °C for 10–14 h (exponential phase).
Spheroplasts from Candida SC5314 were prepared following a
slight modiﬁcation of the procedure reported by Li and Cutler [50].
Exponential-phase yeast cells were washed with 50 mM Tris/HCl,
pH 7.5, containing 0.25 M sucrose and 10 mM EDTA (disodium salt).
Cellswere pelleted by centrifugation at 1500 g for 10 min and suspended
with the same buffer (2 mL/g wet weight) containing Zymolase 20T at
80 units per g wet weight of yeast cells. After incubation at 36 °C for
60 min under continuous agitation, cells were pelleted centrifuging at
1500 g for 30 min. Cells were osmotically shocked by suspension in
50 mM Tris/HCl, pH 7.5, and cell debris were removed by centrifugation
at 3000 g for 10 min. The mitochondrial pellet was eliminated by
centrifugation at 15,000 g for 20 min and the microsomal fraction
was collected after centrifugation at 6500 g for 30 min [51].
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ing 5 mMpotassium phosphate, pH 7.8, 0.25 M sucrose and 3 mMKCl.
The plasmamembranewas isolated by loading themicrosomal suspen-
sion (1 g) onto an aqueous two phase polymer system to give a ﬁnal
composition of 6.5% (w/w) Dextran T500, 6.5% (w/w) polyethylene gly-
col, 5 mM potassium phosphate (pH 7.8), 0.25 M sucrose, and 3 mM
KCl. The plasma membrane was further puriﬁed using a two-step
batch procedure. The resulting upper phase was diluted four-fold with
50 mM Tris/HCl, pH 7.5, containing 0.25 M sucrose, and centrifuged at
100,000 g for 30 min. The resultant pellet was resuspended in the
same buffer containing 30% ethylene glycol and stored at −80 °C. All
steps of the isolation procedure were carried out at 4 °C.
In order to check the purity of the plasma membrane, the activity of
the vanadate-sensitiveATPase as amarker enzymewas determined. Cy-
tochrome c oxidase, NADH cytochrome c reductase, and NO3−-sensitive
ATPase activities were used as markers of mitochondria, endoplasmic
reticulum, and tonoplast, respectively. Tests with the markers showed
that, as a mean value of the isolations performed, ATPase speciﬁc activ-
ity was 66% higher in the plasma membrane than in the microsomal
fraction; vanadate inhibited ATPase activity by 88% in the plasmamem-
brane fractions and by 35% in the microsomal ones. The addition of
KNO3 negligibly reduced ATPase activity in the plasma membrane frac-
tions (6% inhibition). The speciﬁc activities of marker enzymes such as
cytochrome c oxidase and NADH cytochrome c reductase in the upper
phase of both plasma membrane were 4 and 8% of those determined
in the lower phase, respectively.
2.3. Spin labeling
Plasma membrane vesicles were suspended in 500 μL of 50 mM
Tris/HCl, pH 7.5, and some aliquots were used to detect protein amounts
following a previously reported procedure [52]. Spin labeling was per-
formed incubating overnight at room temperature aliquots of mem-
branes containing 300 μg protein with 1.5 μmol of 5-DSA or 16-DSA.
Membranes were then washed three times in 50 mM Tris/HCl, pH 7.5,
and centrifuged at 100,000 g for 15 min. Free spin probes were not
detected in the supernatant following the third washing.
2.4. EPR measurements
For EPR measurements, each sample was transferred into a 100 μL
capillary tube which was sealed at both ends, inserted into a quartz
sample holder, and put in the microwave cavity of the spectrometer.
EPR spectra were recorded using a Varian (Palo Alto, CA, USA) E112
spectrometer operating at X band. Spectra were recorded every 5 °C
in the 0–40 °C interval on temperature raising, waiting 10 min for
equilibrating the temperature. For each spectrum a microwave power
of 2 mW and a modulation amplitude of 1.0 Gauss were employed.
The rigid limit spectrawere recorded at−150 °C using amicrowave
power of 2 mW and a modulation amplitude of 2.0 Gauss.
2.5. Line shape analysis
The EPR spectral line shapes were analyzed using the non-linear-
least-squares ﬁtting program developed by Budil et al. [53], based on
the Freed's theory of slow motion EPR [54,55]. The microscopically or-
dered and macroscopically disordered (MOMD) model proposed by
Meirovitch et al. [56,57] was used to reproduce the characteristics of
the dynamic structure of themembrane samples, where lipidmolecules
are locally oriented by the bilayer structure, but globally the lipid bilayer
segments are distributed randomly. The motion of the nitroxide moiety
attached to the Cn position of the stearic acid chain (Fig. 2) was treated
as Brownian axial diffusion and described by two diffusion coefﬁcients:
R∥, representing the rotation of the spin probe about its long axis, and
R⊥, governing thewobbling of the long axis within a cone. The order pa-
rameter, S, is a measure of the angular extent of the rotational diffusionof the principal nitroxide axis systemwith respect to the membrane di-
rector, which is perpendicular to the bilayer plane. The larger the S
value, themore restricted is themotion,which usuallymeans that later-
ally the lipid molecules surrounding the nitroxide are packed more
tightly.
Our spectra were insensitive to R∥, as already pointed out for EPR
spectra of macroscopically unaligned bilayers by other authors
[58,59]; therefore, in all the calculations R∥ was kept ﬁxed at a value of
108–109 s−1. Each spectrum was ﬁtted by the sum of two sub-spectra,
each characterized by a population and a couple of R⊥ and S ﬁt param-
eters. In the calculations the following values were employed for the
principal components of the g and hyperﬁne interaction (A) tensors:
gxx = 2.0088, gyy = 2.0061, gzz = 2.0027; Axx = Ayy = 5.5 Gauss,
Azz = 34.4 Gauss for the a component of 5-DSA and Axx = Ayy = 4.9
Gauss, Azz = 32.6 Gauss for the a and b components of 16-DSA. These
values were determined from the rigid limit spectra of the different
samples, for which they were found to be equal within 0.2 Gauss. For
the b component of the 5-DSA spectra the same principal components
of the g tensor were used but with Axx = Ayy = 5.1 Gauss and
Azz = 33.4 Gauss. A Lorentzian line width tensor (wxx, wyy, wzz) was
employed to take into account inhomogeneous broadening [53] with
wxx = wyy = wzz. Values of wii of 4.6 and 1.1 Gauss were used for
the a and b components of the 5-DSA spectra, respectively. The values
of wii used for calculating 16-DSA spectra were of 4.6 and 2.4 Gauss
for the a and b components, respectively, except for the 16DSA-FLC
sample, for which the wii values of the b component were taken to be
1.1 Gauss. 30 orientations were considered in all calculations.
3. Results and discussion
3.1. EPR spectra of C. albicans plasma membrane: identiﬁcation of lipid
domains
X-band EPR spectra inmembranes isolated from C. albicans cells, un-
treated (sample nDSA-control, with n = 5 and 16) and treated with
CPA18, CPA109, or FLC (samples nDSA-CPA18, nDSA-CPA109, and
nDSA-FLC, respectively, with n = 5 and 16), were recorded every 5 °C
in the 0 °C to 40 °C temperature range using 5-DSA and 16-DSA spin
probes; a representative selection is shown in Figs. 3 and 4. As it can
be observed, the spectra show up to three distinguishable components,
with characteristic features indicated with a, b, and c in Figs. 3 and 4,
corresponding to spin probes in different environments. In particular,
a minor component (c, indicated by arrows in Figs. 3A and 4D), with a
line shape typical of spin probes undergoing fast isotropic motion, was
observed in some cases. On the basis of the isotropic hyperﬁne coupling
constant (15.6 Gauss),whichwas almost equal to that of the spin probes
in buffer solution, and considering that the line shape does not vary
much with temperature, this component was attributed to a negligible
fraction of spin probe molecules not incorporated in the membrane
bilayer, which remains free in the surrounding buffer. Therefore, this
component was not considered in the line shape analysis and in the
discussion reported below. The main spectral components were due
to spin probes inserted in the membrane bilayer. In particular, the 5-
DSA spectra (Fig. 3) were essentially ascribable to strongly immobilized
spin probes (component a) with only aminor contribution fromweakly
immobilized ones (component b). On the other hand, the spectra
recorded using the 16-DSA spin probe (Fig. 4) showed a strongly
(a) and a weakly (b) immobilized components with comparable rela-
tive intensities. By increasing the temperature, a line shape evolution
characteristic of a general increase inmobility of both spin probes inside
the membrane bilayer was observed for all the samples; indeed, the
outer hyperﬁne splitting of the a component and the line widths of
the b component decreased on heating (Figs. 3 and 4). In particular, as
shown in Fig. 5, the outer hyperﬁne splittings (2Azz) of the a component
in the 5-DSA spectra ranged between 66.0 ± 0.3 Gauss and 57.8 ± 0.3
Gauss on going from 0 °C to 40 °C, while the distances between the
Fig. 3. Experimental and calculated EPR spectra of samples 5DSA-control (A), 5DSA-FLC (B), 5DSA-CPA18 (C) and 5DSA-CPA109 (D) at the indicated temperatures.
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vestigated temperatures. The maximum splittings of the a and b com-
ponents in the spectra of 16-DSA were more difﬁcult to determine
due to the superposition of the two components; however, values rang-
ing from 62 ± 1 Gauss (at 0 °C) to 51 ± 2 Gauss (at 40 °C) could be
measured for the a component in the different samples, whereas for
the b component the maximum splitting was of 28.3 ± 0.3 Gauss for
all the samples at all the temperatures. Moreover, the outer hyperﬁne
splittings (2Azz) determined from the rigid limit spectra of 5-DSA and
16-DSA in the different samples were of 68.8 ± 0.3 Gauss and
65.2 ± 0.3 Gauss, respectively, indicating that, as expected, there is a
decreasing gradient of hydrophobicity on going from the membraneFig. 4. Experimental and calculated EPR spectra of samples 16DSA-control (A), 16DSA-interior to the region close to the surface [60–62]. The isotropic hyper-
ﬁne splitting determined for the b component of the 5-DSA spectra
(14 Gauss) ismuch lower than that determined from the hyperﬁne ten-
sor components (15.1 Gauss). On the basis of this ﬁnding and of the al-
most isotropic line shape, the b component can be ascribed to a minor
fraction of disordered lipids present in the samples [45,63–65].
In protein containing membranes, the a and b spectral components
observed for 16-DSA can be ascribed to lipids interacting with intra-
membraneous proteins and to bulk lipids, respectively [43–46]. In
C. albicans plasmamembrane, where many integral proteins are prefer-
entially associated with highly ordered lipid domains formed by ergos-
terol and sphingolipids segregating from a more disordered phaseFLC (B), 16DSA-CPA18 (C) and 16DSA-CPA109 (D) at the indicated temperatures.
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16-DSA spectra could therefore arise from spin probes in protein–lipid
domains. Indeed, in the time frame for X-band EPR (100 ps to 10 ns),
the spectra of 16-DSA are sharp in disordered lipid domains and broad
in ordered lipid domains around integral membrane proteins (bound-
ary lipids) or trapped between protein molecules (trapped lipids). On
the other hand, both bulk and protein-interacting lipid components
show broad sub-spectra for 5-DSA, which cannot be discriminated in
X-band spectra; in the 5-DSA spectra of our samples they both contrib-
ute to the a component.
In order to determine the relative amount of spin probes in the dif-
ferent environments and to characterize their degree of orientational
order and dynamics, we performed a nonlinear least squares ﬁtting of
the experimental spectra based on the theory of slow motion EPR
[53]. As reported in Section 2.5, we considered an MOMD model
[56,57] for the description of the lipid bilayers and an axial Brownian ro-
tational diffusion model for the spin probe motion. Since the a and b
components of the 5-DSA and 16-DSA spectra are distinguishable at
all the investigated temperatures, we considered the translational diffu-
sion of the spin probes between the different domains slow and we
ﬁtted the spectra as the superposition of two sub-spectra corresponding
to the a and b components (see Fig. 6), each calculated optimizing the
values of the rotational diffusion coefﬁcient R⊥ and the order parameter
S (see Section 2.5) and of the relative population. However, as pointed
out by Ge and Freed [58], the X-band EPR spectra of unaligned lipid bi-
layer samples have limited resolution, the superposition of spectra from
all bilayer director orientations giving rise to inhomogeneous broaden-
ing that tends tomask the homogeneous broadening relating to themo-
lecular dynamics. As a result, theﬁtting of the spectra can be ambiguous.
Here, the superposition of two spectral components could be a further
source of ambiguity in the ﬁtting. Indeed, in the case of 16-DSA spectra,
a quite strong correlationwas found between R⊥ and S for the a compo-
nent, whereas populations and R⊥ and S values for the b component
could be more reliably determined. For the 5-DSA spectra, being their
intensity very small, the R⊥ and S parameters of the b component
were determinedwith a higher uncertainty. All this considered, popula-
tions and R⊥ and S parameters of the a component could be determined
without ambiguity. Adopting this strategy, the line shape of all the re-
corded spectra was satisfactorily reproduced, as exempliﬁed in Figs. 3
and 4, and ordering and dynamic parameters and weights for the com-
ponent spectra could be determined, althoughwith a different degree of
uncertainty. Nevertheless, in all cases they could be used to interpret
trends related to temperature change and sample treatment.
For the 5-DSA spectra, the a component accounted for 97–99%, 92–
98%, 94–99%, and 95–99% of the total spectral intensity for samples
5DSA-control, 5DSA-FLC, 5DSA-CPA18, and 5DSA-CPA109, respectively,
the contribution decreasing with increasing the temperature. The R⊥
and S values, reported in Fig. 5, were typical of lipids with relatively
high mobility and high degree of orientational order. In all cases, the
R⊥ and S values regularly increased and decreased with increasing the
temperature, respectively; in particular, the trends of R⊥ vs T could be
well reproduced by the Arrhenius equation giving activation energy
values of 31 ± 2, 28 ± 2, 23 ± 2, and 26 ± 2 kJ/mol for 5DSA-
control, 5DSA-FLC, 5DSA-CPA18, and 5DSA-CPA109 samples, respec-
tively. These values are in the order of those found for othermembranes
and phospholipid bilayers [66,67], the slightly lower values found for
the treated samples indicating a lower sensitivity of these systems to
temperature changes with respect to the control. The minor b compo-
nent in the 5-DSA spectra of the different samples was characterizedFig. 5. (A) 2Azz valuesmeasured for the a component from the spectra of 5-DSA-control, 5-
DSA-FLC, 5DSA-CPA18, and 5DSA-CPA109 samples. (B) Orientational order parameter
(S) vs T of the a spectral component of 5-DSA in the indicated samples; lines are drawn
to guide the eyes. (C) LogR⊥ vs 1000/T of the a spectral component of 5-DSA in the indicated
samples; lines represent ﬁts to the Arrhenius equation.
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tively, these values being compatible with an environment with quite
high mobility and almost isotropic ordering. For the 16-DSA spectra,
the a component accounted for 78–82%, 45–51%, 52–61%, and 55–66%
of the total spectral intensity for samples 16DSA-control, 16DSA-FLC,
16DSA-CPA18, and 16DSA-CPA109, respectively, the contribution de-
creasing with increasing the temperature. This component was charac-
terized by quite high orientational order and quite slow dynamics, the S
values ranging from 0.83 ± 0.03 to 0.45 ± 0.05 (Fig. 7) and R⊥ values
from (3.2 ± 0.4) × 107 to (1.0 ± 0.1) × 108 s−1, on raising the tem-
perature from 0 °C to 40 °C. On the other hand, for the ﬂuid and almost
isotropic b component of 16-DSA spectra, S values ranging from 0.10 to
0.15 were determined for all the samples except for 16DSA-FLC for
which S was 0.05 ± 0.03. The R⊥ values obtained for the b component
ranged from (1.0 ± 0.1) × 108 to (5.0 ± 0.2) × 108 s−1 (Fig. 7) and
their trends vs T could be well reproduced by the Arrhenius equation
with activation energies of 25 ± 2, 22 ± 2, 30 ± 2, and 20 ± 2 kJ/mol
for 16DSA-control, 16DSA-FLC, 16DSA-CPA18, and 16DSA-CPA109
samples, respectively. These activation energy values are on the
order of those determined for 5-DSA, and no clear trend is found as
a function of the azole treatment.
3.2. Effects of the azole treatments on plasma membrane properties
The EPR spectra of 5-DSA and 16-DSA recorded on the different
plasma membrane samples, although with common general features,
showed signiﬁcant differences which can be related to the effect of the
azole treatments on C. albicans cells. In particular, for the membrane
region close to the polar head groups, explored by the 5-DSA spin
probe, a higher ﬂuidity was found for treated samples as indicated by
the lower values of the outer hyperﬁne splitting (Fig. 5A) and by the
lower order parameter values determined from the ﬁtting of the main
spectral component (Fig. 5B). Therefore, the treatment of C. albicans
cells with the azole antifungal agents here investigated seems to loosen
thepacking of themembrane lipids close to the polar headgroup region.Fig. 6. Left: EPR spectrum recorded on the 5DSA-CPA18 sample at 25 °C; upper spectrum: experim
nents. Right: EPR spectrum recorded on the 16DSA-CPA18 sample at 25 °C; upper spectrum: e
components.Moreover, a slightly higher contribution of theb component to the spec-
tral intensity of the 5-DSA spectra was found for the treated samples
with respect to the control one; indeed the b component accounted
for less than 3% of the spectral intensity for 5DSA-control and for less
than 8%, 6% and 5% for 5DSA-FLC, 5DSA-CPA18, and 5DSA-CPA109,
respectively. This could be seen as an increase in content of very ﬂuid
lipid domains in the membrane induced by the treatments.
EPR spectroscopy with the 5-DSA spin probe was also applied to in-
vestigate the ﬂuidity of plasma membrane in S. cerevisiae strains [35];
lower order parameters were found for strains producing lower levels
of ergosterol. An increased ﬂuidity of the plasma membrane interfacial
region was also found by time-resolved ﬂuorescence spectroscopy for
S. cerevisiae in which the ergosterol content was decreased by an FLC
treatment [33] or usingmutants defective in the late stage of ergosterol
biosynthesis [32,34]. As far as C. albicans is concerned, higher ﬂuidity of
the plasma membrane was also found for FLC resistant strains depleted
in ergosterol [36–39]. In all cases the observed ﬁndingswere ascribed to
the deleterious impact of altered sterols, and in particular of ergosterol
depletion, on membrane packing. Correspondingly, the dramatic de-
crease in ergosterol content previously found for C. albicans treated
with the azoles here investigated [13] can account for the looser packing
in the region close to the lipid head groups. The slightly higher ﬂuidity
found for CPA with respect to FLC treatments could be associated to
the lower free sterol to phospholipid ratio. However, the direct interac-
tion with CPA compounds could also contribute to change the plasma
membrane packing. Indeed, a recent study on the effect of CPA18 and
FLC on the physico-chemical properties of DOPC and DOPC/ergosterol
bilayers, performed by EPR spectroscopy using 5-DSA and 16-DSA as
spin probes, clearly indicated that, both in the presence and in the
absence of ergosterol, CPA18 loosens the phospholipid packing of
DOPC in the region close to the polar head groups and only slightly af-
fects the bilayer core, whereas FLC does not alter the bilayer organiza-
tion and dynamics [68]. Since phosphatidylcholine and ergosterol are
the main phospholipid and sterol components, respectively, of the
C. albicans plasma membrane, in which unsaturated phospholipidsental spectrum and ﬁt; middle and lower spectra: calculated spectra of the b and a compo-
xperimental spectrum and ﬁt; middle and lower spectra: calculated spectra of the b and a
Fig. 7. Top: orientational order parameter (S) vs T of the a spectral component of 16-DSA
in the indicated samples; lines are drawn to guide the eyes. Bottom: LogR⊥ vs 1000/T of
the b spectral component of 16-DSA in the indicated samples; lines represent ﬁts to the
Arrhenius equation.
471C. Sgherri et al. / Biochimica et Biophysica Acta 1838 (2014) 465–473constitute a considerable fraction of total phospholipids [16,69–72], the
direct interactions of the azole compounds observed in themodel bilay-
ers can be considered valid also in the case of the C. albicans plasma
membrane.
The 16-DSA spin probe allowed the effects of the azole treatments to
be investigated close to the core of the plasmamembrane bilayer, giving
information on lipid organization and dynamics as inﬂuenced by the
interactions of lipids with integral proteins. We found that, after the
azole treatments, the amount of spin probes in lipid–protein domains
is markedly decreased, the a component of the 16-DSA spectra account-
ing for ~80%of the spectral intensity for the control sample but for ~50%,
~55%, and ~60% for samples treated with FLC, CPA18 and CPA109,
respectively. On the other hand, no signiﬁcant variations of the order
parameter (S) and diffusion coefﬁcient (R⊥) values were found for this
spectral component among the different samples, indicating that the
azole treatments do not markedly alter the physical state of these
domains. As far as the bulk lipid domain is concerned (spectral compo-
nent b), very low S values were found for all the samples, although no
orientational order of lipids was found only for the sample treatedwith FLC. With respect to the control sample, the R⊥ values were higher
for the CPA18 and FLC treated samples and lower for the CPA109 treated
sample (Fig. 7).
An analysis of the ﬁndings on 16-DSA to obtain detailed quantitative
information on the organization of the plasmamembrane is hampered,
on one hand, by the high structural complexity of the membrane and,
on the other hand, by the lack of knowledge of important parameters
such as the stoichiometry of the protein-associated lipids, a quantity
that is related to the intramembraneous structure and assembly of inte-
gral proteins, the lipid selectivity for the interaction with different
membrane proteins, which depends on the nature of both speciﬁc lipids
and proteins but also on the milieu properties [42–44,46], and the par-
tition coefﬁcient of the spin probe in the different explored domains.
Nevertheless, our ﬁndings can be considered as a strong indication
that the treatment of C. albicans cells with all the azole antifungals test-
ed results in an alteration of the whole plasma membrane structure
concerning not only lipids but also proteins. On the basis of the obtained
data, a decrease in the ratio between integral proteins and lipids, a dif-
ferent organization of lipids to host integral proteins and/or a different
structural arrangement of integral proteins in domains with different
lipid compositions can be inferred. Considering the role of ergosterol
in the organization of the yeast plasmamembrane, it seems reasonable
that the ergosterol depletion by azole antifungals would result in a
decreased formation of highly ordered lipid domains speciﬁcally as-
sociated to integral proteins. To this regard, it is worth mentioning
the presence in C. albicans lipid rafts of a series of proteins involved
in lipid metabolism and multidrug efﬂux, such as: Erg11p and Scs7p,
involved in the lipid metabolism of major raft components [73],
Rta2p, a translocase that moves sphingolipid log chain bases from
the inside to the outside membrane [74], and the ATP-binding cassette
(ABC) multidrug transporter CaCdr1p [31].
4. Conclusions
The application of spin probing EPR spectroscopy allowed the
changes in C. albicansmembrane organization induced by the treatment
of cells in the exponential phase with three azole antifungals (CPA18,
CPA109, and FLC) to be highlighted. In particular, orientational order pa-
rameters, rotational diffusion rates, and populations were determined
for the discernible domains, characterized by different structural and
dynamic properties, by performing an analysis of the line shape of 5-
DSA and 16-DSA spin probe spectra recorded at different temperatures.
It is worth noticing that, although 5-DSA has already been used to probe
the C. albicans membrane close to the lipid polar heads, to the best of
our knowledge this is the ﬁrst report on the use of a spin probe (here
16-DSA) to investigate the core of the plasma membrane bilayers in
C. albicans.
Data obtained for 5-DSA clearly indicate that, regardless of the anti-
fungal agent used, the treatment of the C. albicans cells results in an
increase of the membrane ﬂuidity in proximity of the membrane sur-
face, which can be ascribed to a decrease in ergosterol content, most
probably accompanied by a direct interaction with the phospholipids
in the case of CPA18 and CPA109 compounds. On the other hand, the
16-DSA results point to a deﬁnite decrease in the amount of highly
ordered lipids in domains hosting intramembraneous proteins, which
can be associated with the depletion of ergosterol induced by the treat-
ment with the azole compounds.
In conclusion, treatment of C. albicans cells with azole antifungals,
even in concentrations not able to alter yeast morphology, triggers off
deep alterations in membrane organization.
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